MedPath

Second Generation LMA Versus Endotracheal Tube in Obese Patients

Not Applicable
Completed
Conditions
Endotracheal Tube
Obese
Laryngeal Mask Airway
Interventions
Device: Second-Generation Laryngeal Mask Airway
Registration Number
NCT03748342
Lead Sponsor
University of Texas Southwestern Medical Center
Brief Summary

This prospective, randomized, comparative study is intended to enroll a total of 148 patients with a BMI 30-49.9 kg/m2 undergoing surgery at Parkland Hospital. The efficacy and performance of a second-generation LMA will be compared to endotracheal intubation. A standardized anesthetic protocol that is usual and customary for the type of operation the patient is having will be provided to the anesthesia teams of enrolled subjects. The remainder of the anesthetic care of the subject will not deviate from the standard of care.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
97
Inclusion Criteria
  • 18-80 years old
  • Obese (BMI > or equal to 30 kg/m2
  • Scheduled for a non-emergent surgery that requires general anesthesia (e.g., orthopedic, breast, urological, colorectal, ENT, vascular, general surgery)
  • Willing and able to consent in English or Spanish
  • No current history of advanced pulmonary or cardiac disease
Exclusion Criteria
  • Age less than 18 or older than 80
  • BMI ≥50 or < 30 kg/m2
  • Patient does not speak English or Spanish
  • Expected surgical duration longer than 4 hours
  • Planned postoperative ICU admission
  • Patient refusal
  • Monitored anesthesia care (MAC) or regional anesthesia planned
  • Pregnant or nursing women
  • "Stat" (emergent) cases
  • Known or suspected difficult airway
  • Full stomach/significant aspiration risk (gastroparesis, emergency surgery, untreated moderate to severe gastroesophageal reflux disease, hiatal hernia)
  • No history of gastric surgery
  • Surgery in position other than supine (e.g., Trendelenburg)
  • Laparoscopic surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Second-Generation LMASecond-Generation Laryngeal Mask Airway-
Primary Outcome Measures
NameTimeMethod
Proportion of Participants With Postoperative HypoxiaUp to 80 minutes post-operatively

Patients in the 2 groups will be assessed for postoperative hypoxia (1 or more episodes) in the PACU using a visual analog scale.

Secondary Outcome Measures
NameTimeMethod
Alterations in Blood PressureIntra-operatively

Blood pressure monitor readings (events) will be recorded throughout the surgery and compared to baseline pre-operative values.

Alterations in Heart RateIntra-operatively

Heart rate monitor readings (events) will be recorded throughout the surgery and compared to baseline pre-operative values.

Alterations in Oxygen Saturation (at Baseline)Baseline

Oxygen saturation readings (events) will be recorded throughout the surgery and compared to baseline pre-operative values. Number of participants that did not require O2 is reported in the data table below.

Alterations in Oxygen Saturation (at T15)at 15 mins postoperatively

Oxygen saturation readings (at T15- after 15 mins in PACU) will be recorded throughout the surgery and compared to baseline pre-operative values.

Alterations in Oxygen Saturation (at T45)at 45 mins postoperatively

Oxygen saturation readings (at T45- after 45 mins in PACU) will be recorded throughout the surgery and compared to baseline pre-operative values.

Alterations in Oxygen Saturation (at T80)at 80 mins postoperatively

Oxygen saturation readings (at T80- after 80 mins in PACU) will be recorded throughout the surgery and compared to baseline pre-operative values.

Alterations in Respiratory RateBaseline

Respiratory rate readings (events) will be recorded at baseline.

Trial Locations

Locations (2)

Parkland Health & Hospital System

🇺🇸

Dallas, Texas, United States

MD Anderson Cancer Center

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath